SLC34A3 and nephrocalcinosis: Mutations in the sodium phosphate co-transporters NPT2a [1–3] and NPT2c [4, 5] have been associated with intraluminal stones (nephrolithiasis) and mineral deposits in the renal parenchyma (nephrocalcinosis) in patients with familial forms of hypophosphatemia.